Goldman Sachs initiates coverage on the medical equipment company with a buy rating and a $1,000 price target. Can shares get there?
From Abbott Labs to Wynn, these names rate checking out.
It's a wonder to me how split this market really is.
These three heavily-shorted stocks could pop higher as sellers get it wrong.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.